| Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury L Valentim, KM Laurence, PA Townsend, CJ Carroll, S Soond, ... Journal of molecular and cellular cardiology 40 (6), 846-852, 2006 | 372 | 2006 |
| ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking SM Soond, B Everson, DWH Riches, G Murphy Journal of cell science 118 (11), 2371-2380, 2005 | 318 | 2005 |
| Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level H Pais, FE Nicolas, SM Soond, TE Swingler, IM Clark, A Chantry, ... Rna 16 (3), 489-494, 2010 | 160 | 2010 |
| The biological basis and clinical symptoms of CAR-T therapy-associated toxicites A Titov, A Petukhov, A Staliarova, D Motorin, E Bulatov, O Shuvalov, ... Cell death & disease 9 (9), 897, 2018 | 118 | 2018 |
| Albumin nanovectors in cancer therapy and imaging A Parodi, J Miao, SM Soond, M Rudzińska, AA Zamyatnin Jr Biomolecules 9 (6), 218, 2019 | 107 | 2019 |
| The role of cysteine cathepsins in cancer progression and drug resistance M Rudzińska, A Parodi, SM Soond, AZ Vinarov, DO Korolev, AO Morozov, ... International journal of molecular sciences 20 (14), 3602, 2019 | 105 | 2019 |
| Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT SM Soond, A Chantry Oncogene 30 (21), 2451-2462, 2011 | 100 | 2011 |
| Established and emerging strategies for drug delivery across the blood-brain barrier in brain cancer A Parodi, M Rudzińska, AA Deviatkin, SM Soond, AV Baldin, ... Pharmaceutics 11 (5), 245, 2019 | 65 | 2019 |
| ERK and the F-box protein βTRCP target STAT1 for degradation SM Soond, PA Townsend, SP Barry, RA Knight, DS Latchman, ... Journal of Biological Chemistry 283 (23), 16077-16083, 2008 | 57 | 2008 |
| BH3-mimetics: recent developments in cancer therapy PA Townsend, MV Kozhevnikova, ONF Cexus, AA Zamyatnin, SM Soond Journal of Experimental & Clinical Cancer Research 40, 1-33, 2021 | 56 | 2021 |
| New targets of urocortin-mediated cardioprotection SP Barry, KM Lawrence, J McCormick, SM Soond, M Hubank, S Eaton, ... Journal of Molecular Endocrinology 45 (2), 69-85, 2010 | 52 | 2010 |
| Cysteine cathepsin protease inhibition: an update on its diagnostic, prognostic and therapeutic potential in cancer SM Soond, MV Kozhevnikova, PA Townsend, AA Zamyatnin Jr Pharmaceuticals 12 (2), 87, 2019 | 49 | 2019 |
| Early phase TGFβ receptor signalling dynamics stabilised by the deubiquitinase UCH37 promotes cell migratory responses AJ Cutts, SM Soond, S Powell, A Chantry The international journal of biochemistry & cell biology 43 (4), 604-612, 2011 | 46 | 2011 |
| TRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-κB SM Soond, JL Terry, JD Colbert, DWH Riches Molecular and cellular biology, 2003 | 40 | 2003 |
| STAT1 regulates p73-mediated Bax gene expression SM Soond, C Carroll, PA Townsend, E Sayan, G Melino, I Behrmann, ... FEBS letters 581 (6), 1217-1226, 2007 | 39 | 2007 |
| The DNA and RNA polymerase genes of yeast plasmid pGKL2 are essential loci for plasmid integrity and maintenance R Schaffrath, SM Soond, PA Meacock Microbiology 141 (10), 2591-2599, 1995 | 37 | 1995 |
| How ubiquitination regulates the TGF‐β signalling pathway: New insights and new players: New isoforms of ubiquitin‐activating enzymes in the E1‐E3 families join the game SM Soond, A Chantry Bioessays 33 (10), 749-758, 2011 | 35 | 2011 |
| Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer SM Soond, PG Smith, L Wahl, TE Swingler, IM Clark, AM Hemmings, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (12 …, 2013 | 31 | 2013 |
| Lost or Forgotten: The nuclear cathepsin protein isoforms in cancer SM Soond, MV Kozhevnikova, AS Frolova, LV Savvateeva, EY Plotnikov, ... Cancer letters 462, 43-50, 2019 | 30 | 2019 |
| Kluyveromyces lactis killer plasmid pGKL2: Molecular analysis of an essential gene, ORF5 R Schaffrath, PA Meacock Yeast 11 (7), 615-628, 1995 | 30 | 1995 |
